DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN -01 (2022)

First Author: Jarman E
Attributed to:  MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/liv.15383

PubMed Identifier: 35924447

Publication URI: http://europepmc.org/abstract/MED/35924447

Type: Journal Article/Review

Parent Publication: Liver International

Issue: 1

ISSN: 1478-3223